Shanghai RAAS Blood Products Co Ltd Class A (002252) — Net Asset Momentum
Shanghai RAAS Blood Products Co Ltd Class A (002252) recorded a net asset momentum of 1.6% as of December 2025, with net assets of CN¥32.47 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 002252 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Shanghai RAAS Blood Products Co Ltd Class A Net Asset Momentum (2005–2025)
This chart tracks Shanghai RAAS Blood Products Co Ltd Class A's year-over-year net asset growth across 21 annual reporting periods from 2005 to 2025. The most recent momentum reading is +1.6%, with net assets of CN¥32.47 Billion CNY as of December 2025. Read Shanghai RAAS Blood Products Co Ltd Clas debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)
The table below shows the complete annual net asset history for Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025, covering 21 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 002252 company net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥32.47 Billion | CN¥37.80 Billion | CN¥5.34 Billion | ▲ +1.6% |
| 2024 | CN¥31.94 Billion | CN¥33.63 Billion | CN¥1.69 Billion | ▲ +7.7% |
| 2023 | CN¥29.65 Billion | CN¥31.93 Billion | CN¥2.28 Billion | ▲ +2.9% |
| 2022 | CN¥28.81 Billion | CN¥30.46 Billion | CN¥1.64 Billion | ▲ +11.2% |
| 2021 | CN¥25.90 Billion | CN¥27.24 Billion | CN¥1.33 Billion | ▲ +3.1% |
| 2020 | CN¥25.13 Billion | CN¥25.49 Billion | CN¥363.74 Million | ▲ +118.7% |
| 2019 | CN¥11.49 Billion | CN¥11.85 Billion | CN¥361.95 Million | ▲ +5.4% |
| 2018 | CN¥10.90 Billion | CN¥11.40 Billion | CN¥496.56 Million | ▼ -12.7% |
| 2017 | CN¥12.48 Billion | CN¥14.46 Billion | CN¥1.98 Billion | ▲ +6.4% |
| 2016 | CN¥11.73 Billion | CN¥13.23 Billion | CN¥1.50 Billion | ▲ +9.5% |
| 2015 | CN¥10.71 Billion | CN¥11.56 Billion | CN¥843.64 Million | ▲ +24.2% |
| 2014 | CN¥8.62 Billion | CN¥9.38 Billion | CN¥755.16 Million | ▲ +682.8% |
| 2013 | CN¥1.10 Billion | CN¥1.58 Billion | CN¥473.37 Million | ▲ +8.1% |
| 2012 | CN¥1.02 Billion | CN¥1.21 Billion | CN¥188.79 Million | ▲ +9.9% |
| 2011 | CN¥927.27 Million | CN¥1.01 Billion | CN¥82.26 Million | ▲ +11.6% |
| 2010 | CN¥831.21 Million | CN¥930.33 Million | CN¥99.12 Million | ▲ +8.9% |
| 2009 | CN¥763.33 Million | CN¥825.22 Million | CN¥61.88 Million | ▲ +1.1% |
| 2008 | CN¥754.76 Million | CN¥831.19 Million | CN¥76.42 Million | ▲ +344.0% |
| 2007 | CN¥170.01 Million | CN¥306.54 Million | CN¥136.53 Million | ▲ +8.4% |
| 2006 | CN¥156.77 Million | CN¥325.16 Million | CN¥168.39 Million | ▼ -32.3% |
| 2005 | CN¥231.70 Million | CN¥333.63 Million | CN¥101.93 Million | — |